Skip Navigation

Nucleic Acids Research 2004 32(15):4524-4530; doi:10.1093/nar/gkh789
This Article
Right arrow Full Text Freely available
Right arrow Print PDF (206K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Lindsey-Boltz, L. A.
Right arrow Articles by Sancar, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindsey-Boltz, L. A.
Right arrow Articles by Sancar, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published online 23 August 2004

Nucleic Acids Research, Vol. 32 No. 15 © Oxford University Press 2004; all rights reserved

The human Rad9 checkpoint protein stimulates the carbamoyl phosphate synthetase activity of the multifunctional protein CAD

Laura A. Lindsey-Boltz1, Eric M. Wauson2, Lee M. Graves2,3 and Aziz Sancar1,3,*

1 Department of Biochemistry and Biophysics, 2 Department of Pharmacology and 3 Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27599, USA

* To whom correspondence should be addressed. Tel: +1 919 962 0115; Fax: +1 919 843 8627; Email: Aziz_Sancar{at}med.unc.edu
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors

Received July 23, 2004; Revised and Accepted August 6, 2004

The human Rad9 checkpoint protein is a subunit of the heterotrimeric Rad9-Rad1-Hus1 (9-1-1) complex that plays a role as a damage sensor in the DNA damage checkpoint response. Rad9 has been found to interact with several other proteins outside the context of the 9-1-1 complex with no obvious checkpoint functions. During our studies on the 9-1-1 complex, we found that Rad9 immunoprecipitates contained a 240 kDa protein that was identified as carbamoyl phosphate synthetase/aspartate transcarbamoylase/dihydroorotase (CAD), a multienzymatic protein required for the de novo synthesis of pyrimidine nucleotides and cell growth. Further investigations revealed that only free Rad9, but not Rad9 within the 9-1-1 complex, bound to CAD. The rate-limiting step in de novo pyrimidine nucleotide synthesis is catalyzed by the carbamoyl phosphate synthetase II (CPSase) domain of CAD. We find that Rad9 binds to the CPSase domain, and, moreover, this binding results in a 2-fold stimulation of the CPSase activity of CAD. Similar results were also obtained with an N-terminal Rad9 fragment. These findings suggest that Rad9 may play a role in ribonucleotide biosynthesis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
A. Zhu, C. X. Zhang, and H. B. Lieberman
Rad9 Has a Functional Role in Human Prostate Carcinogenesis
Cancer Res., March 1, 2008; 68(5): 1267 - 1274.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. Jiang and A. Sancar
Recruitment of DNA Damage Checkpoint Proteins to Damage in Transcribed and Nontranscribed Sequences
Mol. Cell. Biol., January 1, 2006; 26(1): 39 - 49.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.